4526

Splicing Modulation as a treatment for cancer or metabolic diseases

Karni Rotem, HUJI, School of Medicine - IMRIC, Biochemistry and Molecular Biology

Category

Life Sciences and Biotechnology   

Keywords

Oncology, Breast Cancer, Splicing Modulation, Metabolic Diseases

 
Summary:
Unbalanced alternative splicing of specific genes is present in several diseases including diabetes and cancer, and more precisely breast cancer. Small molecules or antisense oligonucleotide technology that can restore the normal splicing balance, can also inhibit cancer development and progression. 

Our innovation
Our technology is a new approach to diagnosis and the treatment of certain human breast cancers. We develop small molecules of antisense oligonucleotide that modulate gene splicing for the treatment of cancer where this gene’s splicing is abnormal.

Our innovation opens, for the first time, the possibility of a vaccine against breast cancers.

 

Contact for more information:

Ariela Markel
VP, Business Development, Healthcare
+972-2-6586608
Contact ME: